These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


806 related items for PubMed ID: 19653953

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Knowledge of human papillomavirus (HPV) and the HPV vaccine in a national sample of Australian men and women.
    Pitts MK, Heywood W, Ryall R, Smith AM, Shelley JM, Richters J, Simpson JM.
    Sex Health; 2010 Sep; 7(3):299-303. PubMed ID: 20719218
    [Abstract] [Full Text] [Related]

  • 4. [Knowledge of HPV-related genital lesions and of anti-HPV vaccination in a sample of women of north-eastern Italy].
    Sopracordevole F, Cigolot F, Lucia E, Marchesoni D.
    Minerva Ginecol; 2009 Apr; 61(2):81-7. PubMed ID: 19255555
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. HPV vaccine promotion: does referring to both cervical cancer and genital warts affect intended and actual vaccination behavior?
    Juraskova I, Bari RA, O'Brien MT, McCaffery KJ.
    Womens Health Issues; 2011 Apr; 21(1):71-9. PubMed ID: 21185992
    [Abstract] [Full Text] [Related]

  • 7. Quadrivalent human papillomavirus vaccine.
    Barr E, Tamms G.
    Clin Infect Dis; 2007 Sep 01; 45(5):609-7. PubMed ID: 17682997
    [Abstract] [Full Text] [Related]

  • 8. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.
    Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, Wand H, Fairley CK.
    Lancet Infect Dis; 2011 Jan 01; 11(1):39-44. PubMed ID: 21067976
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Post-licensure monitoring of HPV vaccine in the United States.
    Markowitz LE, Hariri S, Unger ER, Saraiya M, Datta SD, Dunne EF.
    Vaccine; 2010 Jul 05; 28(30):4731-7. PubMed ID: 20188681
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid.
    Cook RL, Zhang J, Mullins J, Kauf T, Brumback B, Steingraber H, Mallison C.
    J Adolesc Health; 2010 Dec 05; 47(6):596-9. PubMed ID: 21094437
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Singaporean women's knowledge of human papillomavirus (HPV) and attitudes toward HPV vaccination.
    Pitts M, Smith A, Croy S, Lyons A, Ryall R, Garland S, Wong ML, Tay EH.
    Women Health; 2009 Jun 05; 49(4):334-51. PubMed ID: 19753508
    [Abstract] [Full Text] [Related]

  • 19. Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme.
    Chow EP, Read TR, Wigan R, Donovan B, Chen MY, Bradshaw CS, Fairley CK.
    Sex Transm Infect; 2015 May 05; 91(3):214-9. PubMed ID: 25305210
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 41.